-
公开(公告)号：US20050208073A1
公开(公告)日：2005-09-22
申请号：US11040670
申请日：2005-01-21
Applicant: Herve Poulet , Frederic David
Inventor： Herve Poulet , Frederic David
IPC: A61K39/12 , A61K39/125 , A61K39/295
CPC classification number: A61K39/125 , A61K39/12 , A61K2039/5252 , A61K2039/54 , A61K2039/545 , A61K2039/552 , A61K2039/55555 , A61K2039/55566 , C12N2770/16034
Abstract: The present invention relates to improved methods and immunogenic and/or vaccine compositions for providing an immune response to feline calicivirus, including hypervirulent strains of feline calicivirus.
Abstract translation: 本发明涉及用于提供对猫杯状病毒的免疫应答的改进方法和免疫原性和/或疫苗组合物，其包括猫杯状病毒的高毒力菌株。
-
2.发明申请Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen 审中-公开包含小隐孢子虫和另一种病原体的抗原的组合物和疫苗公开(公告)号：US20050106163A1
公开(公告)日：2005-05-19
申请号：US10917211
申请日：2004-08-12
Applicant: Frederic David , Francis Milward
Inventor： Frederic David , Francis Milward
IPC: A61K31/07 , A61K31/355 , A61K31/59 , A61K35/20 , A61K39/002 , A61K39/02 , A61K39/108 , A61K39/116 , C07K16/20 , A61K39/295
CPC classification number: A61K31/07 , A61K31/355 , A61K31/59 , A61K35/20 , A61K39/002 , A61K39/0258 , A61K2039/53 , A61K2039/545 , A61K2039/552 , C07K16/20 , C07K2317/12 , Y02A50/474 , Y02A50/488
Abstract: Combination compositions including C. parvum antigen(s) or epitope(s) of interest with at least one other antigen or epitope of interest from a pathogen that causes enteric infection and/or symptoms and/or recombinant(s) and/or vector(s) and/or plasmid(s) expressing such antigen(s) or epitope(s) of interest and administration of such compositions such as to pregnant mammals and/or newborn or young mammals, for instance, pregnant cows and/or calves such as within the first month of birth, are disclosed and claimed.
Abstract translation: 组合组合物包括C.pvv抗原或目的表位与引起肠道感染和/或症状和/或重组和/或载体的病原体感兴趣的至少一种其它抗原或表位 s）和/或表达感兴趣的这种抗原或表位的质粒，并施用这样的组合物，例如怀孕哺乳动物和/或新生儿或幼年哺乳动物，例如怀孕的母牛和/或小牛，例如 在出生的第一个月内，被披露和声明。
-
公开(公告)号：US4027050A
公开(公告)日：1977-05-31
申请号：US594852
申请日：1975-07-10
Applicant: Frederic David Haig
Inventor： Frederic David Haig
CPC classification number: B05B5/032 , B05B5/10 , Y10S148/122
Abstract: A method of coating an article comprising passing a coating material adjacent to a plurality of conductors connected to a high voltage source whereby to electrostatically charge the material and wherein each of the conductors is connected to said source through an impedance adapted to resist reduction of charge on a conductor relatively remote from an articles to be coated in consequence of reduction of charge on a conductor relatively adjacent to said article to be coated. The coating material may be supplied from a powder dispensing and metering device comprising a powder reservoir, a rotor mounted for rotation at the base of the reservoir and an air inlet adjacent the rotor through which air is drawn in use to mix with powder during rotation of the rotor to draw a powder-air mixture away from the reservoir.
Abstract translation: 一种涂覆物品的方法，包括使与涂覆材料相邻的涂层材料连接到连接到高压源的多个导体，从而对材料进行静电充电，并且其中每个导体通过适于阻止电荷降低的阻抗连接到所述源 相对远离待涂覆物品的导体，由于在与所述待涂覆的物品相对相邻的导体上的电荷减少而导致的电荷减少。 涂料可以由粉末分配和计量装置供应，粉末分配和计量装置包括粉末储存器，安装在储存器底部的转子的转子和与转子相邻的空气入口，空气在使用中通过该空气抽吸与粉末在旋转期间混合 转子将粉末 - 空气混合物从储存器中抽出。
-
公开(公告)号：US996494A
公开(公告)日：1911-06-27
申请号：US1910582576
申请日：1910-09-17
Applicant: LOVELL FREDERIC DAVID
Inventor： LOVELL FREDERIC DAVID
CPC classification number: D01B1/10
-
公开(公告)号：USD805860S1
公开(公告)日：2017-12-26
申请号：US29573346
申请日：2016-08-04
Applicant: Frederic David LaRiviere
Designer： Frederic David LaRiviere
-
Patent Agency Ranking
6.发明授权Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom 有权表达狂犬病和OX40蛋白的重组痘病毒载体，以及由其制备的疫苗公开(公告)号：US09567606B2
公开(公告)日：2017-02-14
申请号：US13767603
申请日：2013-02-14
Applicant: Teshome Mebatsion , Jules Maarten Minke , Frederic David
Inventor： Teshome Mebatsion , Jules Maarten Minke , Frederic David
IPC: C12N15/63 , C12N15/86 , C12N15/863 , A61K39/008 , A61K39/12 , A61K39/39 , A61K39/00
CPC classification number: C12N15/86 , A61K39/008 , A61K39/12 , A61K39/205 , A61K39/39 , A61K2039/5256 , A61K2039/53 , A61K2039/552 , A61K2039/55516 , C12N15/8633 , C12N2710/24043 , C12N2760/20134
Abstract: The present invention provides vectors that contain and co-express in vivo or in vitro immunogenic polypeptides or antigens together with an OX40L polypeptide, which functions as a genetic adjuvant. Together, the immunogenic polypeptide and the OX40L polypeptide elicit an immune response in animal or human, which is greater than the immune response elicited by the immunogenic polypeptide alone. In a particular example, the invention provides vectors encoding a Rabies G immunogenic polypeptide and a canine OX40L genetic adjuvant, which vectors elicit strong immune responses in canine against rabies virus.
Abstract translation: 本发明提供载体，其含有体内或体外免疫原性多肽或抗原以及作为遗传佐剂起作用的OX40L多肽的载体。 一起，免疫原性多肽和OX40L多肽在动物或人体中引发免疫应答，其大于单独的免疫原性多肽引起的免疫应答。 在一个具体实例中，本发明提供了编码狂犬病G免疫原性多肽和犬OX40L遗传佐剂的载体，该载体在犬中针对狂犬病病毒引起强烈的免疫应答。
-
公开(公告)号：USD766051S1
公开(公告)日：2016-09-13
申请号：US29523838
申请日：2015-04-14
Applicant: Frederic David LaRiviere
Designer： Frederic David LaRiviere
-
8.发明申请Recombinant Poxviral Vectors Expressing both Rabies and OX40 Proteins, and Vaccines Made Therefrom 有权表达狂犬病和OX40蛋白质的重组痘病毒载体，以及由此产生的疫苗公开(公告)号：US20130209511A1
公开(公告)日：2013-08-15
申请号：US13767603
申请日：2013-02-14
Applicant: Teshome Mebatsion , Jules Maarten Minke , Frederic David
Inventor： Teshome Mebatsion , Jules Maarten Minke , Frederic David
IPC: C12N15/86 , C12N15/863
CPC classification number: C12N15/86 , A61K39/008 , A61K39/12 , A61K39/205 , A61K39/39 , A61K2039/5256 , A61K2039/53 , A61K2039/552 , A61K2039/55516 , C12N15/8633 , C12N2710/24043 , C12N2760/20134
Abstract: The present invention provides vectors that contain and co-express in vivo or in vitro immunogenic polypeptides or antigens together with an OX40L polypeptide, which functions as a genetic adjuvant. Together, the immunogenic polypeptide and the OX40L polypeptide elicit an immune response in animal or human, which is greater than the immune response elicited by the immunogenic polypeptide alone. In a particular example, the invention provides vectors encoding a Rabies G immunogenic polypeptide and a canine OX40L genetic adjuvant, which vectors elicit strong immune responses in canine against rabies virus
Abstract translation: 本发明提供载体，其含有体内或体外免疫原性多肽或抗原以及作为遗传佐剂起作用的OX40L多肽的载体。 一起，免疫原性多肽和OX40L多肽在动物或人体中引发免疫应答，其大于单独的免疫原性多肽引起的免疫应答。 在一个具体实例中，本发明提供了编码狂犬病G免疫原性多肽和犬OX40L遗传佐剂的载体，该载体在犬针对狂犬病毒引起强烈的免疫应答
-
公开(公告)号：USD805861S1
公开(公告)日：2017-12-26
申请号：US29573350
申请日：2016-08-04
Applicant: Frederic David LaRiviere
Designer： Frederic David LaRiviere
-
10.发明申请Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies G 审中-公开基于表达狂犬病的复制缺陷型黄病毒的施用，提供对动物狂犬病长期保护性免疫的新方法公开(公告)号：US20140271708A1
公开(公告)日：2014-09-18
申请号：US13841383
申请日：2013-03-15
Applicant: Frederic David
Inventor： Frederic David
IPC: A61K39/205
CPC classification number: A61K39/205 , A61K39/12 , A61K2039/5252 , A61K2039/5256 , A61K2039/5258 , A61K2039/552 , A61K2039/55505 , C12N2760/20134 , C12N2770/24143
Abstract: The present invention relates to compositions comprising replication defective chimeric flavivirus anti-rabies vaccines, methods of producing the vaccines, and the administration of such vaccines to companion animals, including dogs. The invention further relates to methods for providing long-term protective immunity against rabies in companion animals, including dogs and cats.
Abstract translation: 本发明涉及包含复制缺陷型嵌合黄病毒抗狂犬病疫苗的组合物，生产疫苗的方法以及向包括狗在内的伴侣动物施用此类疫苗。 本发明还涉及用于在伴侣动物（包括狗和猫）中提供针对狂犬病的长期保护性免疫的方法。
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.013 seconds)
